Mark J. Rivard, PhD, DABMP, FAAPM, FABS


Associate Medical Physicist, Rhode Island Hospital

Mark Rivard, Ph.D., DABMP, DABR, FAAPM, FABS, FASTRO, is the chief of brachytherapy physics service and a clinical medical physicist at the Lifespan Cancer Institute

He is certified in radiation oncology physics from the American Board of Medical Physics and therapeutic radiologic physics from the American Board of Radiology.

He has presented at numerous conferences and collaborated on medical research published in academic journals. 

Prior to joining Lifespan, he worked as the chief science officer at CivaTech Oncology Research Triangle Park, North Carolina and several leading medical physics division roles at Tufts Medical Center, as well as other medical, research, and teaching positions.

He earned a master’s in radiological physics and a doctorate in medical physics from Wayne State University in Detroit.

He is a member of the American Association of Physicists in Medicine, the American Brachytherapy Society, the American Society of Therapeutic Radiology and Oncology, the Leksell Gamma Knife Society, and the American Nuclear Society.


Phone: 401-444-5233
Email: [email protected]

Mailing address:
Department of Radiation Oncology
Rhode Island Hospital
593 Eddy Street
Providence, RI  02903

Professor of Radiation Oncology (pending), The Warren Alpert Medical School of Brown University


2018-Present: Associate Medical Physicist, Rhode Island Hospital
2013-2017: Clinical Medical Physicist, consulting professional
2012-2013: Director of Medical Physics Division, Tufts Medical Center, Boston
2004-2012: Chief Medical Physicist, Tufts Medical Center, Boston
2000-2012: Director, Brachytherapy Physics, Tufts Medical Center, Boston
1999-2004: Medical Physicist, Tufts-New England Medical Center, Boston
1996-1997: Assistant Medical Physicist, Gershenson Radiation Oncology Center, Harper Hospital, The Detroit Medical Center, Detroit
1995-1996: Medical Physicist Internship, Gershenson Radiation Oncology Center, Harper Hospital, The Detroit Medical Center, Detroit
1994-1995: Medical Physicist Internship, University of Michigan, Providence Cancer Center, Royal Oak, MI
1990-1995: Research Assistant, University of Michigan at Fermilab, Ann Arbor, MI


1998: PhD, Medical Physics, Wayne State University, Detroit
1995: MSc, Radiological Physics, Wayne State University, Detroit
1992: BSc, Engineering/Physics, University of Michigan, Ann Arbor, MI


  • Rivard MJ, Beaulieu L, Thomadsen BR. Clinical Brachytherapy Physics. American Association of Physicists in Medicine 2017 Summer School Proceedings in Conjunction with the American Brachytherapy Society. (Medical Physics Publishing, 1st Edition, Monograph No. 38, Madison, WI, 2017), ISBN 978-1-936366-57-6 (hardcover book) 978-1-936366-58-3 (ebook), pp. 1-371.
  • Ballester F, Carlsson Tedgren A, Granero D, Haworth A, Mourtada F, Paiva Fonseca G, Zourari K, Papagiannis P, Rivard MJ, Siebert F-A, Sloboda RS, Smith R, Thomson RM, Verhaegen F, Vijande J, Ma Y, Beaulieu L. A generic high-dose-rate 192Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism. Med Phys 2015;42:3048-62.
  • Hiatt JR, Rivard MJ, Hughes HG. Simulation evaluation of NIST air-kerma rate calibration standard for electronic brachytherapy. Med Phys 2016;43:1119-1129.
  • Ulinskas K, Janulionis E, Povilas Valuckas K, Samerdokiene V, Atkocius V, Rivard MJ. Long-term results for stage IIIB cervical cancer patients receiving EBRT combined with either HDR 252Cf or HDR 60Co intracavitary brachytherapy. Brachytherapy 2016;15:353-360.
  • Nath R, Rivard MJ, DeWerd LA, Dezarn WA, Heaton 2nd HT, Ibbott GS, Meigooni AS, Ouhib Z, Rusch TW, Siebert F-A, Venselaar JLM. Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167. Med Phys 2016;43:3178-3205.
  • Quast U, Kaulich TW, Alvarez Romero JT, Carlsson-Tedgren A, Enger SA, Medich DC, Mourtada F, Perez-Calatayud J, Rivard MJ, Zakaria GA. A brachytherapy photon radiation quality index QBT for probe-type dosimetry. Physica Medica 2016;32:741-748.
  • Rivard MJ. A directional 103Pd brachytherapy device: Dosimetric characterization and practical aspects for clinical use. Brachytherapy 2017;16:421-432.
  • Rivard MJ, Ballester, F, Butler WM, DeWerd LA, Ibbott GS, Meigooni AS, Melhus CS, Mitch MG, Nath R, Papagiannis P. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO. Med Phys 2017;44:e297-e338.
  • Ma Y, Vijande J, Ballester F, Carlsson Tedgren Å, Granero D, Haworth A, Mourtada F, Paiva Fonseca G, Zourari K, Papagiannis P, Rivard MJ, Siebert F-A, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L. A generic TG-186 shielded applicator for the commissioning of model-based dose calculation algorithms for high-dose-rate 192Ir brachytherapy. Med Phys 2017;44:5961-5976.
  • Cohen GN, Episcopia K, Lim S-B, LoSasso TJ, Rivard MJ, Taggar AS, Taunk N, Wu AJ, Damato AL. Intraoperative implantation of a mesh of directional palladium sources (CivaSheet): Dosimetry verification, clinical commissioning, dose specification and preliminary experience. Brachytherapy 2017;16:1257-1264.